Radiopharm Theranostics (ASX:RAD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Radiopharm Theranostics (ASX:RAD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Radiopharm Receives $5.9M R&D Tax Incentive
Notification regarding unquoted securities - RAD
Notification of cessation of securities - RAD
Notification of cessation of securities - RAD
Financial Services and Company Secretary Changes
Quarterly Activities/Appendix 4C Cash Flow Report
Radiopharm Theranostics advances clinical trials, reports $19.2M cash with $14.9M quarterly burn
RAD Initial Findings from Phase 1 177Lu-RAD202 Trial
Radiopharm Theranostics Reports Positive Phase 1 Trial Results for 177Lu-RAD202 in HER2+ Tumors
RAD Completes Enrollment in Phase 2b Trial of RAD 101
Radiopharm Completes Phase 2b Trial Enrollment for RAD 101 Brain Metastases Imaging; Plans Phase 3
